Revenue - Kilitch Drugs (India) Ltd (NSE:KILITCH) - Alpha Spread
K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 335.1 INR -0.76% Market Closed
Market Cap: 5.4B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
Revenue Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Revenue
â‚ą1.5B
CAGR 3-Years
25%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
â‚ą289.5B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Revenue
â‚ą261.4B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
â‚ą492.1B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
10%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Revenue
â‚ą206.2B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
10%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
â‚ą110B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
10%

See Also

What is Kilitch Drugs (India) Ltd's Revenue?
Revenue
1.5B INR

Based on the financial report for Jun 30, 2024, Kilitch Drugs (India) Ltd's Revenue amounts to 1.5B INR.

What is Kilitch Drugs (India) Ltd's Revenue growth rate?
Revenue CAGR 5Y
18%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Kilitch Drugs (India) Ltd have been 25% over the past three years , 18% over the past five years .

Back to Top